France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.Merck did not immediately respond to Reuters' request for comment.
"The contract has not yet been finalised, but is in progress," a spokesperson for the commissioner told Reuters on Tuesday. "There must and will be an evaluation, independently of the assessments of regulatory bodies," Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: